Fluorescence-guided Resection of Experimental Malignant Glioma Using Cetuximab-IRDye 800CW

The standard treatment for Glioblastoma Multiforme (GBM) remains maximal safe surgical resection. Here, we evaluated the ability of a systemically administered antibody-dye probe conjugate (cetuximab-IRDye 800CW) to provide sufficient fluorescent contrast for surgical resection of disease in both su...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Neurosurg
Egile Nagusiak: Warram, Jason M., de Boer, Esther, Korb, Melissa, Hartman, Yolanda, Kovar, Joy, Markert, James M., Gillespie, G. Yancey, Rosenthal, Eben L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4740249/
https://ncbi.nlm.nih.gov/pubmed/26073144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02688697.2015.1056090
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak